# ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination

> **NCT00708344** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 832 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Irbesartan - Hydrochlorothiazide
- **DRUG:** Irbesartan - Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00708344
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 832 (ACTUAL)
- **Last updated:** 2010-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00708344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00708344, "ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide Combination". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00708344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*